rs121913255
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Adenocarcinoma of lung (disorder)
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913255
|
|
Adrenocortical carcinoma
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Adrenocortical carcinoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Adrenocortical carcinoma
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Adrenocortical carcinoma
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913255
|
|
Brain Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Brain Neoplasms
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Brain Neoplasms
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Brain Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Chronic Lymphocytic Leukemia
|
C |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Chronic Lymphocytic Leukemia
|
A |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs11554290
|
|
Chronic Lymphocytic Leukemia
|
G |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913255
|
|
Chronic Lymphocytic Leukemia
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121434595
|
|
Colorectal Carcinoma
|
G |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs121913255
|
|
Colorectal Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913250
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
|
21829508 |
2011 |
rs121913250
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913250
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
BRAF mutation predicts sensitivity to MEK inhibition.
|
16273091 |
2006 |
rs121913250
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models.
|
17699718 |
2007 |
rs121913250
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
|
21829508 |
2011 |
rs121913250
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913250
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
NRAS mutations are rare in colorectal cancer.
|
20736745 |
2010 |